Lbp Am Sa Sells 6,292 Shares of Stryker Corporation $SYK

Lbp Am Sa decreased its stake in shares of Stryker Corporation (NYSE:SYK) by 2.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 233,042 shares of the medical technology company’s stock after selling 6,292 shares during the period. Stryker makes up 1.1% of Lbp Am Sa’s investment portfolio, making the stock its 19th largest holding. Lbp Am Sa’s holdings in Stryker were worth $86,149,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of SYK. Mid American Wealth Advisory Group Inc. bought a new position in shares of Stryker in the 2nd quarter worth approximately $26,000. Clayton Financial Group LLC purchased a new position in Stryker during the third quarter valued at $26,000. Elevation Point Wealth Partners LLC bought a new stake in shares of Stryker during the 2nd quarter valued at $28,000. Sachetta LLC increased its stake in shares of Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 27 shares in the last quarter. Finally, Kilter Group LLC purchased a new position in Stryker during the 2nd quarter valued at about $29,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts recently weighed in on SYK shares. Barclays upped their price target on Stryker from $443.00 to $453.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 price target on shares of Stryker in a research note on Friday, November 14th. Evercore ISI set a $390.00 price objective on shares of Stryker in a research note on Monday, January 5th. Wells Fargo & Company raised their price target on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research report on Friday, November 14th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a research report on Monday, December 22nd. Fourteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Stryker currently has an average rating of “Moderate Buy” and an average price target of $430.00.

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 276,173 shares of the firm’s stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the transaction, the director directly owned 2,702,108 shares of the company’s stock, valued at approximately $954,600,714.24. This trade represents a 9.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the sale, the chief accounting officer directly owned 2,833 shares of the company’s stock, valued at $1,035,433.17. This represents a 40.81% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 522,118 shares of company stock worth $185,381,932. Company insiders own 5.20% of the company’s stock.

Stryker Price Performance

NYSE SYK opened at $354.74 on Monday. The stock has a market capitalization of $135.66 billion, a price-to-earnings ratio of 46.62, a PEG ratio of 2.28 and a beta of 0.89. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.85 and a quick ratio of 1.13. The business’s fifty day moving average price is $359.77 and its 200-day moving average price is $372.68.

Stryker (NYSE:SYK) last announced its earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The business had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. During the same period last year, the firm posted $2.87 earnings per share. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. On average, equities analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be issued a dividend of $0.88 per share. This is an increase from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, December 31st. Stryker’s dividend payout ratio is currently 46.25%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.